Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2675 of 2873 entries
View as:

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05205343 Org: User:
Start: 05/11/22 End: 05/31/26 Due: 05/31/27

Multi-center MRD Registry for Inflammatory Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06966050 Org: User:
Start: 05/05/25 End: 05/31/32 Due: 05/31/33

PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT05056207 Org: User:
Start: 11/17/17 End: 11/17/26 Due: 11/17/27

A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06670105 Org: User:
Start: 06/06/25 End: 01/06/32 Due: 01/06/33

A Social Media Approach to Improve Genetic Risk Communication Phase I

Phase: N/A Priority: Normal
NCT ID: NCT01645904 Org: User:
Start: 02/28/13 End: 02/28/21 Due: 02/28/22

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT06162403 Org: User:
Start: 02/22/24 End: 12/31/27 Due: 12/31/28

Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03247088 Org: User:
Start: 07/30/17 End: 12/31/25 Due: 12/31/26

Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00526331 Org: User:
Start: 08/31/07 End: 09/30/08 Due: 09/30/09

Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03488225 Org: User:
Start: 03/28/18 End: 04/02/20 Due: 04/02/21

Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance

Phase: N/A Priority: Normal
NCT ID: NCT01197170 Org: User:
Start: 09/07/10 End: 01/13/21 Due: 01/13/22

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01737619 Org: User:
Start: 04/03/13 End: 12/31/25 Due: 12/31/26

Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)

Phase: N/A Priority: Normal
NCT ID: NCT03053999 Org: User:
Start: 10/09/12 End: 10/31/23 Due: 10/31/24

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02140021 Org: User:
Start: 10/27/14 End: 04/30/26 Due: 04/30/27

Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT02863172 Org: User:
Start: 05/22/12 End: 05/30/25 Due: 05/30/26

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002836 Org: User:
Start: 09/26/95 End: 03/09/06 Due: 03/09/07

Imaging Study Compare 4DCT Image

Phase: N/A Priority: Normal
NCT ID: NCT01626001 Org: User:
Start: 07/31/12 End: 08/31/14 Due: 08/31/15

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05012371 Org: User:
Start: 02/16/22 End: 10/25/25 Due: 10/25/26

Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03680586 Org: User:
Start: 02/04/19 End: 04/30/28 Due: 04/30/29

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04021043 Org: User:
Start: 08/19/19 End: 04/14/25 Due: 04/14/26

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05873192 Org: User:
Start: 09/30/25 End: 12/31/28 Due: 12/31/29

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04776876 Org: User:
Start: 03/01/21 End: 09/02/21 Due: 09/02/22

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05039801 Org: User:
Start: 09/09/21 End: 05/29/26 Due: 05/29/27

Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT04778449 Org: User:
Start: 08/26/15 End: 12/31/26 Due: 12/31/27

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00981201 Org: User:
Start: 11/30/01 End: 09/30/09 Due: 09/30/10

Ipilimumab and Lenalidomide in Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01750983 Org: User:
Start: 03/31/13 End: 02/21/19 Due: 02/21/20